Pang, Peter S.

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Mebazaa, A., Davison, B., Chioncel, O., Cohen-Solal, A., Diaz, R., Filippatos, G., Metra, M., Ponikowski, P., Sliwa, K., Voors, A. A., et al. (2022) · The Lancet

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 1,123

Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association

Kociol, R. D., Cooper, L. T., Fang, J. C., Moslehi, J. J., Pang, P. S., Sabe, M. A., Shah, R. V., Sims, D. B., Thiene, G., Vardeny, O., et al. (2020) · Circulation

Viral Infections and Immunology ResearchMechanical Circulatory Support Devices

Cited by 625

Acute heart failure syndromes

Gheorghiade, M., & Pang, P. S. (2009) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 600

. Effects of serelaxin in patients with acute heart failure

Metra, M., Teerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Pang, P. S., Ponikowski, P., Voors, A. A., et al. (2019) · New England Journal of Medicine

Heart Failure Treatment and ManagementPregnancy-related medical research

Cited by 282

Utility of patient-reported outcome instruments in heart failure

Kelkar, A. A., Spertus, J., Pang, P., Pierson, R. F., Cody, R. J., Pina, I. L., Hernandez, A., & Butler, J. (2016) · JACC: Heart Failure

Heart Failure Treatment and ManagementHealth Education and Validation

Cited by 179

Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis

Teerlink, J. R., Davison, B. A., Cotter, G., Maggioni, A. P., Sato, N., Chioncel, O., Ertl, G., Felker, G. M., Filippatos, G., Greenberg, B. H., et al. (2020) · European Journal of Heart Failure

Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Cited by 41